Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,093 | 39,442 | 56,441 | 37,187 | 61,847 |
| Marketable Securities | 118,371 | 144,930 | 138,807 | 102,614 | 105,760 |
| Receivables | 73,881 | 68,081 | 63,617 | 158,828 | 64,566 |
| Inventories | 46,762 | 47,007 | 40,190 | 40,410 | 30,055 |
| TOTAL | $302,813 | $311,410 | $316,966 | $355,650 | $275,952 |
| Non-Current Assets | |||||
| PPE Net | 50,296 | 50,829 | 51,226 | 51,472 | 51,681 |
| Investments And Advances | 0 | 0 | 3,985 | 0 | 0 |
| Other Non-Current Assets | 22,481 | 23,101 | 23,369 | 24,269 | 24,169 |
| TOTAL | $72,777 | $73,930 | $78,580 | $75,741 | $75,850 |
| Total Assets | $375,590 | $385,340 | $395,546 | $431,391 | $351,802 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,062 | 9,279 | 7,877 | 8,285 | 8,076 |
| Accrued Expenses | 119,398 | 105,639 | 102,950 | 112,341 | 106,117 |
| TOTAL | $133,333 | $119,662 | $115,291 | $124,991 | $118,128 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 335,358 | 336,374 | 335,967 | 259,418 | 252,850 |
| TOTAL | $406,239 | $406,812 | $405,967 | $323,733 | $306,550 |
| Total Liabilities | $539,572 | $526,474 | $521,258 | $448,724 | $424,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,417 | 49,360 | 48,623 | 48,392 | 47,358 |
| Common Shares | 49 | 48 | 48 | 48 | 47 |
| Retained earnings | -1,188,037 | -1,161,211 | -1,141,840 | -1,153,911 | -1,199,444 |
| Other shareholders' equity | -803 | -793 | -430 | -126 | -59 |
| TOTAL | $-163,982 | $-141,134 | $-125,712 | $-17,333 | $-72,876 |
| Total Liabilities And Equity | $375,590 | $385,340 | $395,546 | $431,391 | $351,802 |